Intrinsic Value of S&P & Nasdaq Contact Us

Henry Schein, Inc. HSIC NASDAQ

NASDAQ Global Select • Healthcare • Medical - Distribution • US • USD

SharesGrow Score
51/100
1/7 Pass
SharesGrow Intrinsic Value
$147.54
+91.1%
Analyst Price Target
$90.17
+16.8%

Henry Schein, Inc. (HSIC) generated $712M in operating cash flow for fiscal year 2025. After capital expenditures of $139M, free cash flow was $573M.

Free cash flow margin was 4.3% of revenue. Cash conversion ratio was 1.79x, indicating earnings are backed by cash.

The company returned $850M in share buybacks to shareholders during the period.

Criteria supported by this page:

  • HEALTH (50/100, Partial) — cash generation is adequate but may not fully cover debt in stressed conditions
  • MOAT (53/100, Partial) — cash flow generation is present but not at levels indicating a wide moat
  • INCOME (30/100) — Cash conversion ratio was 1.79x confirms earnings are backed by real cash flow

Overall SharesGrow Score: 51/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
51/100
SG Score
View full scorecard →
~
VALUE
48/100
Price-to-Earnings & upside
→ Valuation
~
FUTURE
46/100
Analyst consensus
→ Forecast
PAST
100/100
→ Income
~
HEALTH
50/100
Debt-to-Equity & liquidity
Proven by this page
~
MOAT
53/100
Proven by this page
GROWTH
30/100
→ Income
INCOME
30/100
→ Income
Henry Schein, Inc. Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $712M$712M$848M$500M$602M
Capital Expenditure $-151M$-139M$-187M$-187M$-96M
Free Cash Flow $561M$573M$661M$313M$506M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message